Search

everythinglearnresearchcommunity

for

Search:↓

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

A defective gene causes hair loss and taste insensitivity in BTBR mice.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

RCS-01 cell therapy is safe and improves skin gene expression.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Thulium laser therapy is a safe and effective short-term treatment for hair regrowth in androgenic alopecia patients.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

HRT helps improve skin issues caused by menopause.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

PRP is more effective than triamcinolone for treating alopecia areata.

TLR4 is important in aging-related diseases and could be a new treatment target.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Triboelectric nanogenerators can use body movement to power therapeutic treatments, potentially transforming personalized healthcare.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Remote photobiomodulation improves brain injury outcomes and behavior in rats.

The study created a new method to test drugs that affect hormone processing in skin.